CLEO Diagnostics Ltd COV
ASX · Australia · Health Technology
AUD 0.32000.00 (0.00%)
Market open· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Australian shares are poised for a modest gain, contrasting with Wall Street's recent declines, as investors navigate global uncertainties and regional developments. In this context, penny stocks—often representing smaller or newer companies—offer intriguing opportunities for growth at accessible price points. Despite being an older term, these stocks can still hold significant potential when backed by strong financial health and solid fundamentals.
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
The Australian market showed a mixed performance recently, with energy stocks leading the way due to geopolitical factors and materials remaining steady. In this context, penny stocks continue to attract attention for their potential to offer unique growth opportunities. Although the term "penny stocks" might seem outdated, these smaller or newer companies can still be promising investments when backed by strong financials and solid fundamentals.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.